Morlacco A - Search Results

1

Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study.

Steuber T, Jilg C, Tennstedt P, De Bruycker A, Tilki D, Decaestecker K, Zilli T, Jereczek-Fossa BA, Wetterauer U, Grosu AL, Schultze-Seemann W, Heinzer H, Graefen M, Morlacco A, Karnes RJ, Ost P. Steuber T, et al. Among authors: morlacco a. Eur Urol Focus. 2019 Nov;5(6):1007-1013. doi: 10.1016/j.euf.2018.02.015. Epub 2018 Mar 10. Eur Urol Focus. 2019. PMID: 29530632

2

Re: Maurice et al: Nonclinical Factors Predict Selection of Initial Observation for Renal Cell Carcinoma (Urology 2015;86:892-900).

Morlacco A, Karnes RJ. Morlacco A, et al. Urology. 2016 Feb;88:229. doi: 10.1016/j.urology.2015.11.031. Epub 2015 Dec 8. Urology. 2016. PMID: 26680243 No abstract available.

3

High-risk prostate cancer: the role of surgical management.

Morlacco A, Karnes RJ. Morlacco A, et al. Crit Rev Oncol Hematol. 2016 Jun;102:135-43. doi: 10.1016/j.critrevonc.2016.04.011. Epub 2016 Apr 27. Crit Rev Oncol Hematol. 2016. PMID: 27155934 Review.

4

Risk-prediction tools in prostate cancer: the challenge of tailoring.

Morlacco A, Pan J, Karnes RJ. Morlacco A, et al. Asian J Androl. 2016 Nov-Dec;18(6):952. doi: 10.4103/1008-682X.179526. Asian J Androl. 2016. PMID: 27212124 Free PMC article. No abstract available.

5

Early salvage radiation therapy post-prostatectomy: key considerations.

Morlacco A, Karnes RJ. Morlacco A, et al. Future Oncol. 2016 Nov;12(22):2579-2587. doi: 10.2217/fon-2016-0208. Epub 2016 Jul 8. Future Oncol. 2016. PMID: 27387852

6

Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series.

Fossati N, Karnes RJ, Boorjian SA, Moschini M, Morlacco A, Bossi A, Seisen T, Cozzarini C, Fiorino C, Noris Chiorda B, Gandaglia G, Dell'Oglio P, Joniau S, Tosco L, Shariat S, Goldner G, Hinkelbein W, Bartkowiak D, Haustermans K, Tombal B, Montorsi F, Van Poppel H, Wiegel T, Briganti A. Fossati N, et al. Among authors: morlacco a. Eur Urol. 2017 Jun;71(6):886-893. doi: 10.1016/j.eururo.2016.07.028. Epub 2016 Jul 30. Eur Urol. 2017. PMID: 27484843

7

Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil.

Zattoni F, Kawashima A, Morlacco A, Davis BJ, Nehra AK, Mynderse LA, Froemming AT, Jeffrey Karnes R. Zattoni F, et al. Among authors: morlacco a. Pract Radiat Oncol. 2017 Jan-Feb;7(1):42-49. doi: 10.1016/j.prro.2016.06.003. Epub 2016 Jun 14. Pract Radiat Oncol. 2017. PMID: 27527896

8

Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-Risk" Prostate Cancer: Implications for Active Surveillance.

Morlacco A, Cheville JC, Rangel LJ, Gearman DJ, Karnes RJ. Morlacco A, et al. Eur Urol. 2017 Sep;72(3):442-447. doi: 10.1016/j.eururo.2016.08.043. Epub 2016 Aug 27. Eur Urol. 2017. PMID: 27574819

9

The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy.

Morlacco A, Sharma V, Viers BR, Rangel LJ, Carlson RE, Froemming AT, Karnes RJ. Morlacco A, et al. Eur Urol. 2017 May;71(5):701-704. doi: 10.1016/j.eururo.2016.08.015. Epub 2016 Aug 28. Eur Urol. 2017. PMID: 27576750

10

The New Prostate Cancer Grading System in High-risk Disease: A Big Step Forward?

Morlacco A, Karnes RJ. Morlacco A, et al. Eur Urol. 2017 Jun;71(6):913-914. doi: 10.1016/j.eururo.2016.11.027. Epub 2016 Dec 9. Eur Urol. 2017. PMID: 27940154 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters